DiviDrip · RNAC

RNAC — Cartesian Therapeutics, Inc.

RNAC is Cartesian Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $9.12. Market cap: $275M. Capital Quality Rank: 3/100 — Systemic risk.

Stock snapshot

Price$9.12
Market cap$275M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)3 / 100 · Systemic risk
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About RNAC

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Listed2016Employees75HQFrederick, MDSectorHealthcareWebsitecartesiantherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RNAC. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RNAC's current stock price?

RNAC (Cartesian Therapeutics, Inc.) is currently trading at $9.12.

Does RNAC pay a dividend?

RNAC (Cartesian Therapeutics, Inc.) does not currently pay a regular dividend.

What is RNAC's Capital Quality Rank?

RNAC has a Capital Quality Rank of 3/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RNAC in DiviDrip

Add RNAC to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow